A Study in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) Receiving Vedolizumab in Real-World Practice in Switzerland

CompletedOBSERVATIONAL
Enrollment

92

Participants

Timeline

Start Date

September 8, 2021

Primary Completion Date

May 17, 2024

Study Completion Date

May 17, 2024

Conditions
Inflammatory Bowel DiseasesCrohns DiseaseColitis, Ulcerative
Trial Locations (6)

3010

Bauchzentrum INSELSPITAL, Universitatsspital Bern, Bern

3012

Gastroenterologische Praxis Balsiger, Seibold & Partner Crohn-Colitis-Zentrum, Bern

4002

Clarunis AG, Basel

8048

Zentrum fur Gastroenterologie und Hepatologie AG, Zurich

8091

Universitatsspital Zurich, Zurich

9007

Kantonsspital St. Gallen, Sankt Gallen

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Takeda

INDUSTRY